Fatty Acid Binding Protein 1 (FABP1) ELISA Kit is a kit for the detection of Fatty Acid Binding Protein 1.
The global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit market was valued at US$ 9 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Fatty acid-binding protein 1 (FABP1), also known as liver-type fatty acid-binding protein (L-FABP), is a small molecular protein mainly expressed in the liver and responsible for transporting and binding fatty acids in cells. This ELISA kit can evaluate fatty acid metabolism and liver function by detecting the concentration of FABP1 in the sample.
This report aims to provide a comprehensive presentation of the global market for Fatty Acid Binding Protein 1 (FABP1) ELISA Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Acid Binding Protein 1 (FABP1) ELISA Kit.
Report Scope
The Fatty Acid Binding Protein 1 (FABP1) ELISA Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Acid Binding Protein 1 (FABP1) ELISA Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Elabscience Biotechnology Inc.
CLOUD-CLONE CORP.
Wuhan Fine Biotech Co., Ltd.
MyBiosource, Inc.
Bio-Techne
Abbexa
Abcam
Hycult Biotech
LifeSpan BioSciences, Inc
Biomatik
Assay Genie
Innovative Research
Creative Diagnostics
Boster Biological Technology
Geno Technology, Inc.
ZodelBiotec Ltd.
Segment by Type
Human
Mouse
Rat
Chicken
Porcine
Others
Segment by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fatty Acid Binding Protein 1 (FABP1) ELISA Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fatty Acid Binding Protein 1 (FABP1) ELISA Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Overview
1.1 Product Overview and Scope of Fatty Acid Binding Protein 1 (FABP1) ELISA Kit
1.2 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Segment by Type
1.2.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Human
1.2.3 Mouse
1.2.4 Rat
1.2.5 Chicken
1.2.6 Porcine
1.2.7 Others
1.3 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Segment by Application
1.3.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue 2019-2030
1.4.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales 2019-2030
1.4.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Competition by Manufacturers
2.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Average Price by Manufacturers (2019-2024)
2.4 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fatty Acid Binding Protein 1 (FABP1) ELISA Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fatty Acid Binding Protein 1 (FABP1) ELISA Kit, Product Type & Application
2.7 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Competitive Situation and Trends
2.7.1 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Players 麻豆原创 Share by Revenue
2.7.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Retrospective 麻豆原创 Scenario by Region
3.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Region: 2019-2030
3.2.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Region: 2019-2024
3.2.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Region: 2025-2030
3.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Region: 2019-2030
3.3.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Region: 2019-2024
3.3.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Region: 2025-2030
3.4 North America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Facts & Figures by Country
3.4.1 North America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Country (2019-2030)
3.4.3 North America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Facts & Figures by Country
3.5.1 Europe Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Country (2019-2030)
3.5.3 Europe Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Country (2019-2030)
3.6.3 Asia Pacific Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Country (2019-2030)
3.7.3 Latin America Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Type (2019-2030)
4.1.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Type (2019-2024)
4.1.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Type (2025-2030)
4.1.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Type (2019-2030)
4.2.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Type (2019-2024)
4.2.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Type (2025-2030)
4.2.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Application (2019-2030)
5.1.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Application (2019-2024)
5.1.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales by Application (2025-2030)
5.1.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Application (2019-2030)
5.2.1 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Application (2019-2024)
5.2.2 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue by Application (2025-2030)
5.2.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Elabscience Biotechnology Inc.
6.1.1 Elabscience Biotechnology Inc. Corporation Information
6.1.2 Elabscience Biotechnology Inc. Description and Business Overview
6.1.3 Elabscience Biotechnology Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Elabscience Biotechnology Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.1.5 Elabscience Biotechnology Inc. Recent Developments/Updates
6.2 CLOUD-CLONE CORP.
6.2.1 CLOUD-CLONE CORP. Corporation Information
6.2.2 CLOUD-CLONE CORP. Description and Business Overview
6.2.3 CLOUD-CLONE CORP. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CLOUD-CLONE CORP. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.2.5 CLOUD-CLONE CORP. Recent Developments/Updates
6.3 Wuhan Fine Biotech Co., Ltd.
6.3.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.3.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.3.3 Wuhan Fine Biotech Co., Ltd. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Wuhan Fine Biotech Co., Ltd. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.3.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.4 MyBiosource, Inc.
6.4.1 MyBiosource, Inc. Corporation Information
6.4.2 MyBiosource, Inc. Description and Business Overview
6.4.3 MyBiosource, Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MyBiosource, Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.4.5 MyBiosource, Inc. Recent Developments/Updates
6.5 Bio-Techne
6.5.1 Bio-Techne Corporation Information
6.5.2 Bio-Techne Description and Business Overview
6.5.3 Bio-Techne Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Techne Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.5.5 Bio-Techne Recent Developments/Updates
6.6 Abbexa
6.6.1 Abbexa Corporation Information
6.6.2 Abbexa Description and Business Overview
6.6.3 Abbexa Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abbexa Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.6.5 Abbexa Recent Developments/Updates
6.7 Abcam
6.6.1 Abcam Corporation Information
6.6.2 Abcam Description and Business Overview
6.6.3 Abcam Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abcam Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.7.5 Abcam Recent Developments/Updates
6.8 Hycult Biotech
6.8.1 Hycult Biotech Corporation Information
6.8.2 Hycult Biotech Description and Business Overview
6.8.3 Hycult Biotech Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hycult Biotech Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.8.5 Hycult Biotech Recent Developments/Updates
6.9 LifeSpan BioSciences, Inc
6.9.1 LifeSpan BioSciences, Inc Corporation Information
6.9.2 LifeSpan BioSciences, Inc Description and Business Overview
6.9.3 LifeSpan BioSciences, Inc Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 LifeSpan BioSciences, Inc Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.9.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.10 Biomatik
6.10.1 Biomatik Corporation Information
6.10.2 Biomatik Description and Business Overview
6.10.3 Biomatik Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biomatik Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.10.5 Biomatik Recent Developments/Updates
6.11 Assay Genie
6.11.1 Assay Genie Corporation Information
6.11.2 Assay Genie Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Description and Business Overview
6.11.3 Assay Genie Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Assay Genie Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.11.5 Assay Genie Recent Developments/Updates
6.12 Innovative Research
6.12.1 Innovative Research Corporation Information
6.12.2 Innovative Research Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Description and Business Overview
6.12.3 Innovative Research Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Innovative Research Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.12.5 Innovative Research Recent Developments/Updates
6.13 Creative Diagnostics
6.13.1 Creative Diagnostics Corporation Information
6.13.2 Creative Diagnostics Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Description and Business Overview
6.13.3 Creative Diagnostics Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Creative Diagnostics Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.13.5 Creative Diagnostics Recent Developments/Updates
6.14 Boster Biological Technology
6.14.1 Boster Biological Technology Corporation Information
6.14.2 Boster Biological Technology Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Description and Business Overview
6.14.3 Boster Biological Technology Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Boster Biological Technology Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.14.5 Boster Biological Technology Recent Developments/Updates
6.15 Geno Technology, Inc.
6.15.1 Geno Technology, Inc. Corporation Information
6.15.2 Geno Technology, Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Description and Business Overview
6.15.3 Geno Technology, Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Geno Technology, Inc. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.15.5 Geno Technology, Inc. Recent Developments/Updates
6.16 ZodelBiotec Ltd.
6.16.1 ZodelBiotec Ltd. Corporation Information
6.16.2 ZodelBiotec Ltd. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Description and Business Overview
6.16.3 ZodelBiotec Ltd. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales, Revenue and Gross Margin (2019-2024)
6.16.4 ZodelBiotec Ltd. Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Product Portfolio
6.16.5 ZodelBiotec Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Industry Chain Analysis
7.2 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Production Mode & Process
7.4 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales and 麻豆原创ing
7.4.1 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Sales Channels
7.4.2 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Distributors
7.5 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Customers
8 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Dynamics
8.1 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit Industry Trends
8.2 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Drivers
8.3 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Challenges
8.4 Fatty Acid Binding Protein 1 (FABP1) ELISA Kit 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Elabscience Biotechnology Inc.
CLOUD-CLONE CORP.
Wuhan Fine Biotech Co., Ltd.
MyBiosource, Inc.
Bio-Techne
Abbexa
Abcam
Hycult Biotech
LifeSpan BioSciences, Inc
Biomatik
Assay Genie
Innovative Research
Creative Diagnostics
Boster Biological Technology
Geno Technology, Inc.
ZodelBiotec Ltd.
听
听
*If Applicable.